Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Kabra Drugs Ltd

NSE: KABRADG · BSE: 524322 · Pharmaceuticals & Biotechnology · 5 announcements

Share price: ₹18.76
Market cap: ₹44.48 Cr
Revenue (annual): ₹92.74 Cr
Net profit (annual): ₹4.96 Cr
P/E (TTM): 5.9×Sector 50.4×
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

12 Aug 2026 18:58 IST BSE

Financial Results

Kabra Drugs Q1 FY27 Results: Turns Profitable, Net Profit ₹2.1 Cr

Kabra Drugs Ltd reported revenue from operations of ₹46.2 Cr (+541.7% YoY) and net profit of ₹2.1 Cr for Q1 FY27.

Key figure: Net profit ₹2.1 Cr

Open full results → Read the filing ↗